Three-dimensional structure of complement receptor type 2 and uses thereof
US8858945B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2013 |
| Grant date | Oct 14, 2014 |
| Priority date | — |
| Expiry date | Jun 13, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2299/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a crystalline human CR2 protein in complex with C3d, and the three dimensional structure of the crystalline complex. Also disclosed are methods of use of the structure, particularly for structure-based identification of compounds that bind to CR2 and inhibit or enhance the binding of CR2 to a natural ligand, that bind to CR2 and agonize or antagonize the receptor, that bind to CR2 and inhibit or enhance CR2 dimerization, or that use the C3-binding ability of CR2 as a drug delivery vehicle. Also disclosed are therapeutic compounds obtained by such methods and uses for such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.